Preventing pneumothorax during lung cancer treatment

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial investigates the use of pleural embolization, specifically a technique known as pleural blood patch (PBP), to prevent pneumothorax in patients undergoing thermal ablation for lung cancer. Pneumothorax is a common complication that can lead to the need for chest drains, which are associated with additional morbidity. The study aims to assess the effectiveness of PBP in reducing the incidence of pneumothorax and the subsequent need for drainage procedures. By utilizing autologous blood to seal air leaks, the trial seeks to improve patient outcomes and recovery times following lung ablation.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Clinically indicated for lung ablation.
* Willing and capable of giving informed consent.
* Aged 18 years or above.

Exclusion Criteria:

* Unable to proceed to lung ablation procedure.
* 3 or more lung lesions to be ablated in the same setting.

Where it's running

• Oxford University Hospitals NHS Foundation Trust
  Oxford, United Kingdom Recruiting

Study contacts

• Principal investigator: Dr Yan-Lin Li Consultant Interventional Radiologist, EBIR FRCR FHKAM — Oxford University Hospitals NHS Foundation Trust/ University of Oxford
• Study coordinator: Dr Yan-Lin Li Consultant Interventional Radiologist, EBIR FRCR FHKAM
• Email: yan-lin.li@ouh.nhs.uk
• Phone: 44 1865 235746

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Fluorescent abenacianine to help surgeons find lung tumors during surgery

  This tests whether a fluorescent drug called abenacianine helps surgeons see and remove lung cancer or lung metastases during planned lung surgery in adults.

  Recruiting at 9 sites Phase 3 Vergent Bioscience, Inc. · Duarte, California and 8 other locations · NCT07499674

• ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden

  This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.

  Recruiting Tongji Hospital · Hubei, Wuhan · NCT07912190

• Urine VOC Test to Detect Lung Cancer in Never Smokers

  A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.

  Recruiting Thomas Jefferson University · Philadelphia, Pennsylvania · NCT07871656

• SI-B036 safety test in advanced and metastatic solid tumors

  This early-phase study checks whether SI-B036 is safe and tolerable in adults with advanced or metastatic solid cancers who have had prior therapy.

  Recruiting at 4 sites Phase 1 SystImmune Inc. · New Haven, Connecticut and 6 other locations · NCT07857616

• Guaraná Supplement for Cancer-Related Fatigue in People Undergoing Treatment

  This study tests whether taking guaraná capsules helps reduce cancer-related fatigue and improve quality of life in adults with breast, lung, colorectal, or gastric cancer who are actively receiving treatment.

  Recruiting Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo · Bogotá, Bogota D.C. · NCT07816263

• ENPP1/cGAS and FAP in Solid Tumors in Vietnamese Patients

  This Vietnam-based study will test ENPP1, cGAS, and FAP expression in archived tumor samples from Vietnamese adults with solid cancers using immunohistochemistry.

  Recruiting at 2 sites Tam Anh Research Institute · Hanoi, Hanoi and 1 other locations · NCT07808164

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.